Literature DB >> 18597624

Age-dependent demise of GNAS-mutated skeletal stem cells and "normalization" of fibrous dysplasia of bone.

Sergei A Kuznetsov1, Natasha Cherman, Mara Riminucci, Michael T Collins, Pamela Gehron Robey, Paolo Bianco.   

Abstract

We studied the role of somatic mosaicism in fibrous dysplasia of bone (FD) within the context of skeletal ("mesenchymal") stem cells by assessing the frequency of mutated colony forming unit-fibroblasts (CFU-Fs) from FD lesions, and in some cases, from unaffected sites, in a series of patients. There was a tight inverse correlation between the percentage mutant CFU-F versus age, suggesting demise of mutant stem cells caused by exuberant apoptosis noted in samples from young patients. In older patients, either partially or completely normal bone/marrow histology was observed. On in vivo transplantation, FD ossicles were generated only by cell strains in which mutant CFU-Fs were identified. Strains that lacked mutant CFU-F (but were mutation positive) failed to regenerate an FD ossicle. These data indicate that GNAS mutations are only pathogenic when in clonogenic skeletal stem cells. From these data, we have evolved the novel concept of "normalization" of FD. As a lesion ages, mutant stem cells fail to self-renew, and their progeny are consumed by apoptosis, whereas residual normal stem cells survive, self-renew, and enable formation of a normal structure. This suggests that activating GNAS mutations disrupt a pathway that is required for skeletal stem cell self-renewal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18597624      PMCID: PMC2585500          DOI: 10.1359/jbmr.080609

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  23 in total

1.  Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts.

Authors:  P H Krebsbach; S A Kuznetsov; K Satomura; R V Emmons; D W Rowe; P G Robey
Journal:  Transplantation       Date:  1997-04-27       Impact factor: 4.939

2.  Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo.

Authors:  S A Kuznetsov; P H Krebsbach; K Satomura; J Kerr; M Riminucci; D Benayahu; P G Robey
Journal:  J Bone Miner Res       Date:  1997-09       Impact factor: 6.741

3.  Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.

Authors:  P J Marie; C de Pollak; P Chanson; A Lomri
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

4.  Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment.

Authors:  Benedetto Sacchetti; Alessia Funari; Stefano Michienzi; Silvia Di Cesare; Stefania Piersanti; Isabella Saggio; Enrico Tagliafico; Stefano Ferrari; Pamela Gehron Robey; Mara Riminucci; Paolo Bianco
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

5.  Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines.

Authors:  R L Jilka; R S Weinstein; T Bellido; A M Parfitt; S C Manolagas
Journal:  J Bone Miner Res       Date:  1998-05       Impact factor: 6.741

6.  The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks.

Authors:  M Riminucci; B Liu; A Corsi; A Shenker; A M Spiegel; P G Robey; P Bianco
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

7.  An animal model of fibrous dysplasia.

Authors:  P Bianco; P G Robey
Journal:  Mol Med Today       Date:  1999-07

8.  Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.

Authors:  M Riminucci; L W Fisher; A Shenker; A M Spiegel; P Bianco; P Gehron Robey
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

9.  Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells.

Authors:  P Bianco; S A Kuznetsov; M Riminucci; L W Fisher; A M Spiegel; P G Robey
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

10.  The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow.

Authors:  Sergei A Kuznetsov; Mara Riminucci; Navid Ziran; Takeo W Tsutsui; Alessandro Corsi; Laura Calvi; Henry M Kronenberg; Ernestina Schipani; Pamela Gehron Robey; Paolo Bianco
Journal:  J Cell Biol       Date:  2004-12-20       Impact factor: 10.539

View more
  48 in total

1.  "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease.

Authors:  Paolo Bianco; Pamela Gehron Robey; Isabella Saggio; Mara Riminucci
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

2.  Successful Intravascular Treatment of an Intraosseous Arteriovenous Fistula in Fibrous Dysplasia.

Authors:  Kristen S Pan; Luis F de Castro; Kelly L Roszko; Edward D Greenberg; Edmond J FitzGibbon; Craig R Dufresne; Alison M Boyce; Michael T Collins
Journal:  Calcif Tissue Int       Date:  2020-06-17       Impact factor: 4.333

3.  Fibrous dysplasia: an unusual case of a very aggressive form with costo-vertebral joint destruction and invasion of the contralateral D7 vertebral body.

Authors:  Carmine Zoccali; Dario Attala; Barbara Rossi; Giovanni Zoccali; Virginia Ferraresi
Journal:  Skeletal Radiol       Date:  2018-05-23       Impact factor: 2.199

Review 4.  Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.

Authors:  D Ovejero; Y H Lim; A M Boyce; R I Gafni; E McCarthy; T A Nguyen; L F Eichenfield; C M C DeKlotz; L C Guthrie; L L Tosi; P S Thornton; K A Choate; M T Collins
Journal:  Osteoporos Int       Date:  2016-08-06       Impact factor: 4.507

Review 5.  Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.

Authors:  Cemre Robinson; Michael T Collins; Alison M Boyce
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

6.  Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone.

Authors:  Pablo Florenzano; Kristen S Pan; Sydney M Brown; Scott M Paul; Harvey Kushner; Lori C Guthrie; Luis Fernandez de Castro; Michael T Collins; Alison M Boyce
Journal:  J Bone Miner Res       Date:  2019-01-15       Impact factor: 6.741

Review 7.  DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.

Authors:  Luis F de Castro; Diana Ovejero; Alison M Boyce
Journal:  Eur J Endocrinol       Date:  2020-05       Impact factor: 6.664

Review 8.  Fibrous dysplasia and fibroblast growth factor-23 regulation.

Authors:  Alison M Boyce; Nisan Bhattacharyya; Michael T Collins
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

9.  GNAS Mutations in Fibrous Dysplasia: A Comparative Study of Standard Sequencing and Locked Nucleic Acid PCR Sequencing on Decalcified and Nondecalcified Formalin-fixed Paraffin-embedded Tissues.

Authors:  George Jour; Alifya Oultache; Justyna Sadowska; Talia Mitchell; John Healey; Khedoudja Nafa; Meera Hameed
Journal:  Appl Immunohistochem Mol Morphol       Date:  2016-10

10.  Fibrous Dysplasia and Medication-Related Osteonecrosis of the Jaw.

Authors:  Tarek Metwally; Andrea Burke; Jeffrey Y Tsai; Michael T Collins; Alison M Boyce
Journal:  J Oral Maxillofac Surg       Date:  2016-04-07       Impact factor: 1.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.